Carlyle Group Inc.
- SEC CIK
- 0001527166
- Latest filing
- Aug 7, 2026
The latest 13F from Carlyle Group Inc. covers Q2 2026 (filed Aug 7, 2026): 19 long positions worth $10.0B. The top 10 holdings make up 99.9% of the portfolio, and the largest is Medline Inc. (MDLN) at 73.8%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 3
- Est. +$1.33M
- Added
- 2
- Est. +$1.45M
- Reduced
- 2
- Est. −$13.3M
- Sold out
- 4
- Est. −$9.30M
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $10.0B
- −$618.2M (−5.8%) vs. prior quarter
- Positions
- 19
- −1 vs. prior quarter
- Top 10 concentration
- 99.9%
- Top 10 as share of value
- Turnover
- <0.1%
- Q2 2026, one quarter
- Average holding period
- 4.1 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $14.8B (Q2 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | 19 | $10.0B | MDLNSAROPHAT | vs. Q1 2026 | SEC |
| Q1 2026 | May 8, 2026 | 20 | $10.6B | MDLNSAROPHAT | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 13, 2026 | 20 | $13.6B | MDLNSAROPHAT | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 7, 2025 | 17 | $4.34B | SAROPONYPHAT | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 8, 2025 | 20 | $5.03B | SAROSLNOPHAT | vs. Q1 2025 | SEC |
| Q1 2025 | May 9, 2025 | 23 | $3.80B | SAROSLNOWRD | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 13, 2025 | 27 | $4.15B | SAROSLNOWRD | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 8, 2024 | 26 | $953.3M | QDELSLNOGTM | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 9, 2024 | 31 | $1.05B | QDELGTMSLNO | vs. Q1 2024 | SEC |
| Q1 2024 | May 3, 2024 | 32 | $1.59B | QDELGTMSLNO | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 2, 2024 | 25 | $2.08B | QDELGTMSLNO | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 3, 2023 | 25 | $2.31B | QDELGTMMKSI | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 4, 2023 | 26 | $2.81B | QDELGTMMKSI | vs. Q1 2023 | SEC |
| Q1 2023 | May 5, 2023 | 30 | $3.35B | QDELGTMMKSI | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 10, 2023 | 13 | $3.44B | GTMQDELMKSI | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 10, 2022 | 11 | $3.15B | GTMQDELMKSI | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 12, 2022 | 9 | $5.80B | Atotech LtdGTMQDEL | vs. Q1 2022 | SEC |
| Q1 2022 | May 13, 2022 | 7 | $8.36B | Atotech LtdGTMOCDX | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 11, 2022 | 8 | $9.62B | Atotech LtdGTMOCDX | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 12, 2021 | 10 | $12.6B | GTMAtotech LtdPPD | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 12, 2021 | 10 | $14.8B | GTMAtotech LtdOCDX | vs. Q1 2021 | SEC |
| Q1 2021 | May 14, 2021 | 12 | $13.2B | GTMAtotech LtdOCDX | – | SEC |
13D and 13G filings
Companies where Carlyle Group Inc. reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
3 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| SAROStandardAero, Inc. | 13G/A | 25.40%84.6M shares | −20.20 ppfrom 45.60% | Feb 12, 20254 filings | May 15, 2026 | SEC |
| MDLNMedline Inc. | 13G/A | 20.60%187.1M shares | −3.80 ppfrom 24.40% | Feb 13, 20262 filings | May 15, 2026 | SEC |
| VISNVistance Networks, Inc. | 13D/A | 17.50%45.9M shares | +0.20 ppfrom 17.30% | Jul 27, 20224 filings | Aug 5, 2025 | SEC |
Latest filings
90 filings on file made by Carlyle Group Inc. or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| SPWRSunPower Inc. | Aug 14, 20267:00 AM ET | 13G/A | 4.40%8.30M shares | −1.00 ppfrom 5.40%Below 5% | Jun 30, 2026 | SEC |
| QTTBQ32 Bio Inc. | Jul 6, 20267:20 PM ET | 13G/A | 4.10%691.7K shares | –Below 5% | Jun 30, 2026 | SEC |
| SAROStandardAero, Inc. | May 15, 20264:30 PM ET | 13G/A | 25.40%84.6M shares | −20.20 ppfrom 45.60% | Mar 31, 2026 | SEC |
| MDLNMedline Inc. | May 15, 20264:30 PM ET | 13G/A | 20.60%187.1M shares | −3.80 ppfrom 24.40% | Mar 31, 2026 | SEC |
| JSPRJasper Therapeutics, Inc. | Feb 18, 20265:29 PM ET | 13D/A | 3.80%1.09M shares | –Below 5% | Feb 18, 2026 | SEC |
| SPRBSpruce Biosciences, Inc. | Feb 18, 20265:27 PM ET | 13D/A | 4.70%50.9K shares | –Below 5% | Feb 18, 2026 | SEC |
| MDLNMedline Inc. | Feb 13, 20264:30 PM ET | 13G | 24.40%215.3M shares | New | Dec 31, 2025 | SEC |
| SPWRSunPower Inc. | Feb 13, 20264:30 PM ET | 13G/A | 5.40%6.39M shares | −2.70 ppfrom 8.10% | Dec 31, 2025 | SEC |
| SPWRSunPower Inc. | Nov 13, 20254:30 PM ET | 13G/A | 8.10%7.21M shares | – | Sep 30, 2025 | SEC |
| PHATPhathom Pharmaceuticals, Inc. | Aug 28, 20254:30 PM ET | 13G/A | 4.90%3.50M shares | –Below 5% | Aug 28, 2025 | SEC |
| SAROStandardAero, Inc. | Aug 12, 20254:30 PM ET | 13G/A | 45.60%152.7M shares | −8.50 ppfrom 54.10% | Jun 30, 2025 | SEC |
| VISNVistance Networks, Inc. | Aug 5, 20254:10 PM ET | 13D/A | 17.50%45.9M shares | +0.20 ppfrom 17.30% | Aug 3, 2025 | SEC |
| SAROStandardAero, Inc. | May 13, 20254:30 PM ET | 13G/A | 54.10%180.8M shares | −8.70 ppfrom 62.80% | Mar 31, 2025 | SEC |
| BSMBlack Stone Minerals, L.P. | May 13, 20254:30 PM ET | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2025 | SEC |
| NCNANuCana plc | Apr 18, 20256:04 PM ET | 13D/A | 2.40%3.43M shares | –Below 5% | Apr 18, 2025 | SEC |
| VISNVistance Networks, Inc. | Apr 2, 20254:30 PM ET | 13D/A | 17.30%45.2M shares | – | Mar 31, 2025 | SEC |
| SAROStandardAero, Inc. | Feb 12, 20256:03 PM ET | 13G | 62.80%210.2M shares | New | Dec 31, 2024 | SEC |
| QDELQuidelOrtho Corp | Nov 21, 2024 | 13D/AOld format | – | – | – | SEC |
| GTMZoomInfo Technologies Inc. | Nov 14, 2024 | 13G/AOld format | – | – | – | SEC |
| SPWRSunPower Inc. | Nov 12, 2024 | 13G/AOld format | – | – | – | SEC |